a phase i/ii trial of fixed-dose stereotactic body radiotherapy 1-1-phase diagramm h2ax phosphorylation within the g1 phase after uv electrical and magnetic properties near the magnetic phase bortezomib-mediated downregulation of s-phase kinase protein-2